CRLF2 and lymphoma: Sarno et al. (46) set out to study why high expression of CRLF2 is associated with poor prognosis in patients with B-lymphoblastic leukemia/lymphoma, and identified coordinated signaling involving JAK/STAT, PI3K and CREB pathways downstream of CRLF2.